Low dose NSAIDs and sysadoas in the management of knee osteoarthritis
Aging Clinical and Experimental Research · 2025
DOI: 10.1007/s40520-025-03221-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Aging Clinical and Experimental Research, 2025. Verfasst von Alberto Migliore und 11 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Anti-Inflammatory Agents, Non-Steroidal, Chondroitin Sulfates, Diclofenac. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DSFP of King Saud University, Riyad, Kingdom of Saudi Arabia.
Abstract (Originalsprache)
Introduction
Osteoarthritis (OA) is a chronic, progressive joint disease characterized by the degradation of articular cartilage, subchondral bone remodeling, synovial inflammation, and osteophyte formation. Despite being a leading cause of disability in older people, effective long-term management of OA remains a significant challenge. Current treatment strategies primarily focus on symptom control, with both non-pharmacological and pharmacological interventions. Materials and methods A systematic literature review followed by a structured Delphi survey was conducted, involving an international Technical Expert Panel (TEP) of OA specialists. The panel evaluated the efficacy, safety, and clinical utility of combining low dose diclofenac and chondroitin sulfate in OA management.
Results
The analysis of expert consensus indicated that the combination of low dose diclofenac and chondroitin sulfate may be effective in reducing pain and improving joint function in patients with knee OA. Additionally, this combination could reduce the need for higher doses of NSAIDs, thereby minimizing systemic adverse effects.
Conclusion
The combination of low dose diclofenac and chondroitin sulfate represents a promising therapeutic strategy for managing knee OA. Further studies are needed to confirm these findings and optimize therapeutic strategies to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy.
- Department of Rheumatology and Medical Sciences, Clinical Rheumatology Unit, ASST Gaetano Pini-CTO, Milan, Italy. orazio.delucia@asst-pini-cto.it.
- Physical and Rehabilitative Medicine, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, 88100, Italy.
- Research Center on Musculoskeletal Health, MusculoSkeletalHealth@UMG, University of Catanzaro "Magna Graecia", Catanzaro, 88100, Italy.
- Špecializovaná Nemocnica Pre Ortopedickú Protetiku, Záhradnícka 42, Bratislava, 821 08, Slovakia.
- Orthopedic Clinic, Bratislava, Slovakia.
Förderung
- DSFP of King Saud University, Riyad, Kingdom of Saudi Arabia
Zitieren
APA
Migliore, A., De Lucia, O., de Sire, A., Šajbidor, A., Šenolt, L., Szántó, S., Fontova, J. C., Flechtenmacher, J., Mobasheri, A., Faure, J. M., Reginster, J. Y., & Veronese, N. (2025). Low dose NSAIDs and sysadoas in the management of knee osteoarthritis. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-025-03221-2
Vancouver
Migliore A, De Lucia O, de Sire A, Šajbidor A, Šenolt L, Szántó S, et al. Low dose NSAIDs and sysadoas in the management of knee osteoarthritis. Aging Clinical and Experimental Research. 2025. doi:10.1007/s40520-025-03221-2
BibTeX
@article{Migliore2025,
author = {Migliore, Alberto and De Lucia, Orazio and de Sire, Alessandro and Šajbidor, Andrea and Šenolt, Ladislav and Szántó, Sándor and Fontova, Joan Calvet and Flechtenmacher, Johannes and Mobasheri, Ali and Faure, Jordi Monfort and Reginster, Jean-Yves and Veronese, Nicola},
title = {Low dose NSAIDs and sysadoas in the management of knee osteoarthritis},
journal = {Aging Clinical and Experimental Research},
year = {2025},
doi = {10.1007/s40520-025-03221-2}
}
EUVIMED